Sanofi-Aventis (Canada)

74 articles about Sanofi-Aventis (Canada)

• France Agency Recalls Two Lots Of Sanofi-Aventis (France) Anti Blood-Clotting Drug Plavix

  2/8/2007

• Sanofi-Aventis Appoints Euro RSCG Worldwide, Part Of The Havas Group, As One Of Its Two Strategic Communication Partners, And Now Becomes One Of Havas' Top Three Clients

  11/17/2006

• Sanofi-Aventis (Canada) Release: Important Safety Information About KETEK (Telithromycin)

  10/4/2006

• UCB Group And Sanofi-Aventis (France) Sign A Co-Promotion Agreement For Xyzal(R); In The United States

  9/25/2006

• Cheaper Blood Thinner Just As Effective, Study Says

  8/23/2006

• Sanofi-Aventis (France): Release Of First Half 2006 Sales & Earnings - Wednesday August 2, 2006

  7/21/2006

• Procter & Gamble And Sanofi-Aventis (Canada) Release: New Phase III Data Reports On The Safety And Efficacy Of Risedronate For The Treatment Pf Male Osteoporosis

  6/5/2006

• Sanofi-Aventis (France) Defends Ambien Sleeping Pill

  3/23/2006

• Sanofi-Aventis (France) Ambien May Prompt Sleep-Eating

  3/15/2006

• World Health Organization Calls For Halt On Malaria Treatment

  1/19/2006

• Sanofi-Aventis (France) Release: Analysis From Several Clinical Studies Show Dronedarone Appears To Be Consistently Safe And Effective In Maintaining Normal Sinusal Rhythm And Ventricular Rate Control In Patients With Cardiac Arrhythmia

  11/15/2005

• Sanofi-Aventis Japan To Merge Sanofi-Synthelabo And Aventis Pharma Japan In January

  11/2/2005

• Enzon Pharmaceuticals, Inc. Announces Amendment To ONCASPAR Agreement With Members Of The Sanofi-Aventis (SASY.PA) Group

  10/31/2005

• Europe Suspends Sanofi-Aventis Vaccine On Efficacy Concern

  9/20/2005

• Sanofi-Aventis Release: Interim Analysis Of Phase III Study Shows TAXOTERE(R) (docetaxel)-Based Chemotherapy Regimens Combined With HERCEPTIN(R) (Trastuzumab) Significantly Improved Disease Free Survival In Early-Stage HER2-Positive Breast Cancer

  9/15/2005

• Doubts Over "Metabolic Syndrome" Weigh On Sanofi

  8/25/2005

• Aventis Pharma Obtains Additional Approval for Taxoid Antitumor Agent TAXOTERE Injection

  8/22/2005

• P&G, Sanofi Aventis: The U.S. Food And Drug Administration Approves Actonel(R) With Calcium

  8/15/2005

• Sanofi-Aventis Release: ALLEGRA-D(R) 24 Hour Extended Release Tablets Now Available For Seasonal Allergy Sufferers

  7/28/2005

• Sanofi-Aventis Release: Lovenox(R) Patent Trial Update

  6/16/2005